Lonza Group AG at JPMorgan Healthcare Conference Transcript
Hi. Welcome to the Lonza presentation at the JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan, and it's my great pleasure to introduce the CEO of Lonza, Pierre-Alain Ruffieux. Before I hand over to Pierre-Alain, I would just remind everyone that we will stay in here for the Q&A of the presentation. And so if you'd like to ask a question, then please put your hand up, and there will be mics. And just wait, and we'll come to you. Pierre-Alain, great to see you.
Thank you. Good morning, everybody. A warm welcome to all of you. It's really good to see you after 2 year, back face to face. I think we have already -- we have almost 40 minutes together. In the first part, I'm going to share a brief update on our business. Then I'm looking forward to hear your questions.
The agenda today is the following: I will start with the short company background, highlighting some aspects of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |